2226 Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial

Nobuhiro Takiguchi,Yasuhiro Kodera,Naoto Takahashi,Takaki Yoshikawa,Kazumasa Fujitani,Seiji Ito,Katsufumi Miyamoto,Osamu Takayama,Motohiro Imano,Daisuke Kobayashi,Yumi Miyashita,Satoshi Morita,Junichi Sakamoto

2226 Feasibility of weekly intraperitoneal versus intravenous paclitaxel delivered from the day of radical surgery for gastric cancer: A preliminary safety analysis of INPACT study, a randomized controlled trial

2015

Nobuhiro Takiguchi
Yasuhiro Kodera
Naoto Takahashi
Takaki Yoshikawa
Kazumasa Fujitani
Seiji Ito
Katsufumi Miyamoto
Osamu Takayama
Motohiro Imano
Daisuke Kobayashi
Yumi Miyashita
Satoshi Morita
Junichi Sakamoto

Background Peritoneal carcinomatosis is common after curative resection of gastric cancer. Intraperitoneal administration of paclitaxel (PTX) is known to control ovarian peritoneal metastases.

Keywords:

Randomized controlled trial
Pathology
Paclitaxel
Cancer
General surgery
Anesthesia
Radical surgery
Medicine
Resection
Surgery

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations